Panel Says Generic Drug Launch Does Not Violate Patent Settlement
PHILADELPHIA — A Delaware federal judge’s “thoughtful and thorough” decision rejecting breach of contract claims levied against a generic drug maker was affirmed July 16 by the Third Circuit U.S. Court...To view the full article, register now.
Already a subscriber? Click here to view full article